Safety and Dialysability of Dotarem® in Dialysed Patients
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the dialysability of Dotarem®, after an IV injection of 0.1 mmol/kg in patients
with chronic renal failure who require hemodialysis treatment.